Shenzhen Neptunus Bioengineering Co., Ltd. (SZSE: 000078)
Health Care · Health Care Providers & Services · CN
CN¥1.62
-4.14% today · -41.3% 1Y
Shenzhen Neptunus Bioengineering Co., Ltd. (SZSE: 000078) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $634.06M and employs 6,734 people.
Over the last twelve months the share price has lost 41.3%, trading between 1.27 and 5.70.
Tweenvest scores Shenzhen Neptunus Bioengineering Co., Ltd. across four factors: quality 43/100, value 41/100, growth 6/100. Its strongest factor is quality.
000078 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $634.06M
- Revenue (TTM)
- $3.66B
- P/E
- —
- EPS
- -0.22
- Dividend yield
- —
- Beta (5Y)
- 0.01
- 52-week high
- CN¥5.70
- 52-week low
- CN¥1.27
- Avg volume (3M)
- —
- Shares outstanding
- 2.63B
- Employees
- 6,734
- Next earnings
- —
About Shenzhen Neptunus Bioengineering Co., Ltd.
Shenzhen Neptunus Bioengineering Co., Ltd. is a pharmaceutical enterprise primarily active in China, focusing on the research, development, production, and sale of various medicinal products. Its offerings span therapeutic categories such as anti-cancer treatments, cardiovascular and cerebrovascular medications, and pharmaceuticals derived from marine sources. Founded in 1989, the company is headquartered in Shenzhen, China.
- ISIN
- CNE000000X95
- Founded
- 1992
- Listed since
- Dec 18, 1998
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $355.98B | $397.87 | +0.32% |
| CVS Health CorporationNYSE: CVS | $118.82B | $93.10 | +0.22% |
| McKesson CorporationNYSE: MCK | $105.52B | $906.20 | +0.12% |
| HCA Healthcare, Inc.NYSE: HCA | $92.83B | $430.03 | +0.30% |
| Elevance Health, Inc.NYSE: ELV | $86.50B | $400.02 | +0.29% |
| The Cigna GroupNYSE: CI | $73.81B | $279.99 | +0.24% |
| Cencora, Inc.NYSE: COR | $62.60B | $328.06 | +1.33% |
| Cardinal Health, Inc.NYSE: CAH | $55.33B | $237.99 | +0.03% |
Figures last refreshed Aug 18, 2026.